Stable Heart Failure

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2022-12-27
Clinical Trial Update: Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial of TRC041266 in chronic stable heart failure with diastolic dysfunction and type 2 diabetes mellitus was withdrawn.